The companies will offer compelling quality and value to patients and payers and support independent doctors’ practices as eligible surgical cases (e.g., total joint replacements) continue to migrate to the ASC and surgical hospital environments.Why isn’t smart gun technology on Parkland activists’ agenda?Waning vaccine immunity linked to pertussis resurgenceCould European data privacy rules cost you big?MiraBurst, the world’s largest producer of miracle berry products, is dedicated to helping people reduce their intake of added sugars and sweeteners in their diets.Oncocyte Provides Corporate Update and Reports Second Quarter 2020 Financial ResultsSalarius Announces Proposed Public Offering of Common StockBalloon pulmonary angioplasty for CTEPH improves heart failure symptomsHDAC inhibition may boost immune therapy efficacy in breast cancerThe agreement calls for the acquisition of SCA’s outstanding common stock for a fixed price of $57.00 per share, to be funded between 51 percent and 80 percent with UnitedHealth Group common stock, with the final percentage to be determined at UnitedHealth Group’s option and the remainder in cash. Announces New Board of DirectorsFDA approves IL-23 antagonist for plaque psoriasisTB in 2017: Good news and bad newsFDA approves new option in Hodgkin lymphoma treatmentTeladoc Health Reports Second-Quarter 2020 ResultsFDA expands indication for blinatumomab in treating ALLciTBI uncommon in minor head injuries with isolated vomitingNIH releases COPD National Action PlanSiponimod trial ‘first’ to show delayed disability in secondary progressive MSRanking points physicians toward South DakotaImmune Health Supplements Market to Reach USD 29.40 Billion by 2027; High Demand for Organic & Non-GMO Products to Boost GrowthCytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020Knee Replacement Market to Reach USD 12.48 Billion by 2027; Rising Awareness about Early Diagnosis to Boost Market, states Fortune Business Insights™Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation ImmunotherapiesHope and hype: Inside the push for wearable diabetes technologyWith the combination, SCA will become part of the OptumCare platform, which serves millions of consumers annually through 20,000 affiliated physicians and hundreds of care facilities. About ⦠Addison, Texas-based United Surgical Partners International, Deerfield, Ill.-based Surgical Care Affiliates, Nashville-based HCA Healthcare and Nashville-based Surgery Partners. Hayek and the SCA leadership team will continue forward as part of SCA and the larger OptumCare platform. The companies will offer compelling quality and value to patients and payers and support independent doctors’ practices as eligible surgical cases (e.g., total joint replacements) continue to migrate to the ASC and surgical hospital environments.“Joining with OptumCare will enable us to better support and empower independent physicians, helping them provide high-quality care for their patients while making health care more affordable. In 2020, Optum expects its revenue to â¦â¦ services business, and growth in the Medicare Advantage membership on the health insurance side.
âWe believe this combination will create significant value for SCA's patients and physician partners, and we look forward to the combined companyâs future success.â Affiliates of TPG Capital, owning approximately 30 percent of the common stock of SCA, have agreed to tender their shares as part of the offer.ÂLarry C. Renfro, vice chairman of UnitedHealth Group and Optum chief executive officer, said: âCombining SCA and OptumCare will enable us to continue the transition to high-quality, high-value ambulatory surgical care, partnering with the full range of health systems, medical groups and health plans. We have an incredibly high regard for SCAâs leadership and people, so we look forward to working with them and our payer partners to implement care models that reward independent surgeons and specialists for quality and care efficiency.ââJoining with OptumCare will enable us to better support and empower independent physicians, helping them provide high-quality care for their patients while making health care more affordable. The combination of SCA and OptumCare is another step forward toward our vision of becoming the partner of choice for surgeons,â said Andrew Hayek, chairman and chief executive officer of SCA. Surgical Care Affiliates, Inc. (SCA), is one of the largest providers of outpatient surgery in the United States. Hayek and the SCA leadership team will continue forward as part of SCA and the larger OptumCare platform.
Patient satisfaction is a priority at SCA. The agreement calls for the acquisition of SCA’s outstanding common stock for $57.00 per share.The combination of SCA with OptumCare, Optum’s primary and urgent care delivery services business working with more than 80 health plans, will position the combined organization as a comprehensive provider of ambulatory care services, while continuing expansion of SCA’s network of ASCs and surgical hospitals in partnership with leading health systems, medical groups and health payers.